Cargando…
Benefit of Adjuvant Chemoradiotherapy in Resected Gallbladder Carcinoma
To evaluate the benefit of adjuvant treatments, such as chemoradiotherapy (CRT) and chemotherapy (CTx), compared with no adjuvant treatment (No-AT) in resected gallbladder (GB) cancer patients, 151 patients were analyzed: 98 (64.9%) patients received adjuvant treatment with CRT (n = 59, 39.1%) or CT...
Autores principales: | Kim, Tae Hyun, Woo, Sang Myung, Lee, Woo Jin, Oh, Eun Sang, Youn, Sang Hee, Moon, Sung Ho, Kim, Sang Soo, Han, Sung Sik, Park, Sang-Jae, Kim, Dae Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692378/ https://www.ncbi.nlm.nih.gov/pubmed/31409811 http://dx.doi.org/10.1038/s41598-019-48099-z |
Ejemplares similares
-
Effectiveness and feasibility of concurrent chemoradiotherapy using simultaneous integrated boost-intensity modulated radiotherapy with and without induction chemotherapy for locally advanced pancreatic cancer
por: Oh, Eun Sang, et al.
Publicado: (2018) -
Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
por: Kim, Yeon-Joo, et al.
Publicado: (2013) -
Efficacy and feasibility of proton beam radiotherapy using the simultaneous integrated boost technique for locally advanced pancreatic cancer
por: Kim, Tae Hyun, et al.
Publicado: (2020) -
Effectiveness and Safety of Simultaneous Integrated Boost-Proton Beam Therapy
for Localized Pancreatic Cancer
por: Kim, Tae Hyun, et al.
Publicado: (2018) -
Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04)
por: Lee, Sung Uk, et al.
Publicado: (2022)